MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Rilonacept in Subjects With Cardiac Sarcoidosis
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT06660732
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Mayo Clinic in Rochester, Rochester, Minnesota, United States
Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
Phase 2
Recruiting
- Conditions
- Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT06660407
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Enabling Microbiomics- Driven Personalized Nutrition
- Conditions
- Inflammatory Bowel Disease (IBD)Irritable Bowel Syndrome (IBS)Celiac DiseaseDiarrheaConstipationMicrobiomeCrohn's DiseaseUC - Ulcerative ColitisMicroscopic ColitisFunctional Dyspepsia
- First Posted Date
- 2024-10-24
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 4001
- Registration Number
- NCT06657001
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
Phase 1
Not yet recruiting
- Conditions
- Liver Transplant; ComplicationsLiver Diseases
- Interventions
- Drug: Autologous adipose derived mesenchymal stromal cells (AMSC)
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT06649864
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
Not Applicable
Recruiting
- Conditions
- Crohn's DiseaseAbdominal Pain (AP)
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 15
- Registration Number
- NCT06647615
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate
Not Applicable
Recruiting
- Conditions
- COVID-19 ImmunisationInfluenza Vaccine
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 117780
- Registration Number
- NCT06646406
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
Recruiting
- Conditions
- Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT06640010
- Locations
- 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients with Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Phase 2
Recruiting
- Conditions
- Advanced Fallopian Tube CarcinomaAdvanced Fallopian Tube High Grade Serous AdenocarcinomaAdvanced Ovarian CarcinomaAdvanced Ovarian CarcinosarcomaAdvanced Ovarian Clear Cell AdenocarcinomaAdvanced Ovarian Endometrioid AdenocarcinomaAdvanced Ovarian High Grade Serous AdenocarcinomaAdvanced Primary Peritoneal CarcinomaAdvanced Primary Peritoneal High Grade Serous AdenocarcinomaFallopian Tube Carcinosarcoma
- Interventions
- Procedure: BiopsyProcedure: Biospecimen CollectionProcedure: Computed TomographyBiological: Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine AdsorbedProcedure: LeukapheresisProcedure: Magnetic Resonance ImagingDrug: Placebo Administration
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 78
- Registration Number
- NCT06639074
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Rochester, Rochester, Minnesota, United States
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Phase 2
Recruiting
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Breast CarcinomaTriple-Negative Breast Carcinoma
- Interventions
- Procedure: Biopsy of BreastProcedure: Biospecimen CollectionProcedure: Breast SurgeryDrug: ChemotherapyProcedure: Computed TomographyProcedure: Contrast Enhanced Digital MammographyRadiation: Hypofractionated Radiation TherapyProcedure: Magnetic Resonance ImagingProcedure: Positron Emission TomographyOther: Survey AdministrationProcedure: Tissue CollectionProcedure: Ultrasound Imaging
- First Posted Date
- 2024-10-10
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 120
- Registration Number
- NCT06635980
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Use of Shear Wave Elastography for Intraoperative Brain and Glioma Stiffness Measurements
Not yet recruiting
- Conditions
- GliomaRecurrent Glioma
- Interventions
- Other: Non-Interventional Study
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT06630338
- Locations
- 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath